Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-25-076336
Filing Date
2025-05-22
Accepted
2025-05-22 16:15:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 apvo-2025_-_atm_sticker_.htm 424B5 16038
2 GRAPHIC img27560562_0.jpg GRAPHIC 6172
  Complete submission text file 0000950170-25-076336.txt   25704
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284969 | Film No.: 25977306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)